SCHEMBL24490705

SCHEMBL24490705

CC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 1/20 0.52
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MTNR1A P48039 5/20 0.44
MTNR1B P49286 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HIF1A Q16665 1/20 0.41
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
FOLH1 Q04609 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TLR2 O60603 1/20 0.37
PAOX Q6QHF9 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228717 1.00 ADRA1A (0.52) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL13056634 1.00 ADRA1A (0.52) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL18532464 1.00 ADRA1A (0.52) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL22690587 1.00 ADRA1A (0.52) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL12197743 1.00 ADRA1A (0.52) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL19057218 1.00 ADRA1A (0.52) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL13248321 0.98 ADRA1A (0.53) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL22388820 0.93 ADRA1A (0.46) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL21788052 0.89 ADRA1A (0.58) ADRA1AMEN1KMT2AMTNR1AMTNR1B
SCHEMBL26153487 0.88 ADRA1A (0.44) ADRA1AMEN1KMT2AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177489-A1 Next Generation Synthetic Transcription Factors WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177489-A1 Next Generation Synthetic Transcription Factors ZFX, RUNX1, JUN ADRA1A 4856/4885MEN1 2726/4885KMT2A 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.